InvestorsHub Logo
Followers 0
Posts 115
Boards Moderated 0
Alias Born 09/16/2016

Re: None

Tuesday, 06/06/2017 6:47:49 AM

Tuesday, June 06, 2017 6:47:49 AM

Post# of 672
WAYNE, Pa., June 6, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets, for oral use –CII.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.